Response to BotulinumtoxinA in a migraine cohort with multiple comorbidities and widespread pain
出版年份 2019 全文链接
标题
Response to BotulinumtoxinA in a migraine cohort with multiple comorbidities and widespread pain
作者
关键词
-
出版物
REGIONAL ANESTHESIA AND PAIN MEDICINE
Volume 44, Issue 6, Pages 660-668
出版商
BMJ
发表日期
2019-05-17
DOI
10.1136/rapm-2018-100196
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study
- (2017) Elif Ilgaz Aydinlar et al. JOURNAL OF HEADACHE AND PAIN
- Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
- (2016) David W. Dodick et al. HEADACHE
- A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability
- (2016) Richard B. Lipton et al. HEADACHE
- Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study
- (2016) Hongwei Zhang et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Evidence from diverse clinical populations supported clinical validity of PROMIS pain interference and pain behavior
- (2016) Robert L. Askew et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions
- (2016) Karon F. Cook et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year
- (2016) I. Aicua-Rapun et al. JOURNAL OF HEADACHE AND PAIN
- Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment
- (2016) Simona Guerzoni et al. JOURNAL OF HEADACHE AND PAIN
- Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
- (2016) Katja Kollewe et al. JOURNAL OF NEURAL TRANSMISSION
- United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot Data
- (2016) Michael Von Korff et al. JOURNAL OF PAIN
- Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
- (2016) Bekir Enes Demiryurek et al. NEUROLOGICAL SCIENCES
- The use of onabotulinum toxin A (Botox®) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study
- (2016) Marco Russo et al. NEUROLOGICAL SCIENCES
- Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine
- (2015) Kasra Maasumi et al. HEADACHE
- Frequency of Migraine Headaches in Patients With Fibromyalgia
- (2015) Brinder Vij et al. HEADACHE
- Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study
- (2015) Dawn C. Buse et al. HEADACHE
- O051. Chronic migraine and onabotulinumtoxinA: a prospective study on patients treated at the Headache Centre of the Padua University and analysis of possible predictors of responsivity
- (2015) Caterina Disco et al. JOURNAL OF HEADACHE AND PAIN
- A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
- (2015) Andrea Negro et al. JOURNAL OF HEADACHE AND PAIN
- Physical and Psychological Correlates of Fatigue and Physical Function: A Collaborative Health Outcomes Information Registry (CHOIR) Study
- (2015) John A. Sturgeon et al. JOURNAL OF PAIN
- OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
- (2015) María Isabel Pedraza et al. SpringerPlus
- Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
- (2014) Eva Cernuda-Morollón et al. CEPHALALGIA
- Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
- (2014) Modar Khalil et al. JOURNAL OF HEADACHE AND PAIN
- From Catastrophizing to Recovery: a pilot study of a single-session treatment for pain catastrophizing
- (2014) Beth Darnall et al. Journal of Pain Research
- Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective study
- (2013) Kuan-Hsiang Lin et al. Journal of the Chinese Medical Association
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
- (2010) D C Buse et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started